Author: Sadikot, Ruxana T.; Kolanjiyil, Arun V.; Kleinstreuer, Clement; Rubinstein, Israel
Title: Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome Document date: 2017_6_27
ID: 27gutwjd_17
Snippet: We have also tested the efficacy of TREM1 nanomicellar peptides in a model of LPSinduced sepsis and lung injury. TREM proteins are a family of immunoglobulin cell surface receptors expressed on myeloid cells. TREM1 was the first TREM identified, and blockade of TREM1 has been shown to improve survival in animal models of sepsis [33] . We have extensively studied the mechanisms by which TREM1 amplifies inflammation [30] [31] [32] [33] [34] . Previ.....
Document: We have also tested the efficacy of TREM1 nanomicellar peptides in a model of LPSinduced sepsis and lung injury. TREM proteins are a family of immunoglobulin cell surface receptors expressed on myeloid cells. TREM1 was the first TREM identified, and blockade of TREM1 has been shown to improve survival in animal models of sepsis [33] . We have extensively studied the mechanisms by which TREM1 amplifies inflammation [30] [31] [32] [33] [34] . Previous studies where TREM1 blockade was used therapeutically in models of sepsis and infection employed fusion proteins (soluble or extracellular components of TREM1) [23, 33] . These peptides are limited by their short half-life and therefore may not be practical for therapeutic purposes.
Search related documents:
Co phrase search for related documents- animal model and extracellular soluble component: 1
- animal model and fusion protein: 1, 2, 3, 4, 5
- animal model and half life: 1, 2, 3, 4
- animal model and infection sepsis: 1
- animal model and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- animal model and mechanism study: 1, 2, 3, 4, 5, 6, 7, 8, 9
- animal model and previous study: 1, 2, 3, 4, 5, 6, 7
- animal model and sepsis animal model: 1, 2, 3
- animal model and sepsis animal model survival: 1
- animal model and therapeutic purpose: 1, 2
- animal model and trem protein: 1
- animal model and TREM1 extracellular soluble component: 1
- cell surface and fusion protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- cell surface and half life: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cell surface and immunoglobulin cell surface receptor: 1, 2
- cell surface and infection sepsis: 1
- cell surface and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- cell surface and mechanism study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- cell surface and myeloid cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date